stockrowEnvista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) Revenue growth
Envista Holdings Corporation's revenue growth over the twelve months to 30 September 2026 was 9.78%, up 1.5 percentage points from fiscal 2025 (8.32%). Over the past ten years it has ranged from −19.7% (fiscal 2019) to 30.1% (fiscal 2021); the current reading is higher than 90% of that period. That is above the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 8.32% | 10.50 |
| FY2024 | −2.18% | (2.08) |
| FY2023 | −0.10% | (2.50) |
| FY2022 | 2.40% | (27.66) |
| FY2021 | 30.1% | 45.63 |
| FY2020 | −15.6% | 4.11 |
| FY2019 | −19.7% | (20.88) |
| FY2018 | 1.20% | 0.27 |
| FY2017 | 0.93% | 1.85 |
| FY2016 | −0.92% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 3.22% | (3.88) |
| Jun 2026 | 7.10% | (7.26) |
| Mar 2026 | 14.4% | (0.60) |
| Dec 2025 | 15.0% | 3.50 |
| 28 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 90.1% |
| TFX Teleflex Incorporated compare | 30.7% |
| ATRC AtriCure, Inc. compare | 13.8% |
| STVN Stevanato Group S.p.A. compare | 11.6% |
| WRBY Warby Parker Inc. compare | 9.89% |
| NVST Envista Holdings Corporation | 9.78% |
| MMSI Merit Medical Systems, Inc. compare | 9.06% |
| ICUI ICU Medical, Inc. compare | −5.92% |
| MMED MiniMed Group, Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on NVST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement